Etoposide/topotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35321-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：181 / 181

相关论文

共 50 条

[1] Carboplatin/etoposide/topotecanLack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 126 - 126
[2] Etoposide/TopotecanLack of efficacy
Reactions Weekly, 2024, 2003 (1) : 380 - 380
[3] TopotecanLack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 436 - 436
[4] Melphalan/topotecanLack of efficacy: case report
Reactions Weekly, 2022, 1928 (1) : 229 - 229
[5] Ipilimumab/nivolumab/topotecanLack of efficacy and reactivation of tuberculosis: case report
Reactions Weekly, 2021, 1852 (1) : 249 - 249
[6] Cyclophosphamide/filgrastim/topotecanLack of efficacy and ureaplasma parvum infection: case report
Reactions Weekly, 2025, 2055 (1) : 119 - 119
[7] Etoposide/ImmunotherapiesLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 164 - 164
[8] Etoposide/immunoglobulinsLack of efficacy: case report
Reactions Weekly, 2025, 2054 (1) : 170 - 170
[9] Etoposide/filgrastimLack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 188 - 188
[10] Etoposide/PazopanibLack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 198 - 198

← 1 2 3 4 5 →